Zapping stomach tumors with calcium: a new way to stop bleeding?

NCT ID NCT07647731

Not yet recruiting Disease control Sponsor: Hospital del Rio Hortega Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a procedure called calcium electroporation to stop bleeding from stomach cancer tumors. Doctors inject calcium into the tumor and use a special device to deliver small electrical pulses, which can help control bleeding. The trial will include 28 patients with advanced stomach cancer who have limited treatment options, and the goal is to see if the procedure safely reduces or stops bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: calcium gluconate
What this could lead to: If it works, this could offer a minimally invasive way to control tumor bleeding and improve quality of life for gastric cancer patients who cannot have surgery or strong treatments.
What could go wrong: This is a very early, small study (28 people) with no comparison group, so results may not apply broadly. The procedure may not stop bleeding or could cause side effects like pain or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CALCIUM ELECTROPORATION FOR HEMOSTASIS IN GASTRIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CALCIUM ELECTROPORATION FOR HEMOSTASIS IN GASTRIC NEOPLASMS

More trials for these conditions

Other studies related to the condition(s) this trial covers.